These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 29141849)
1. Polycystic Ovary Syndrome, Oligomenorrhea, and Risk of Ovarian Cancer Histotypes: Evidence from the Ovarian Cancer Association Consortium. Harris HR; Babic A; Webb PM; Nagle CM; Jordan SJ; Risch HA; Rossing MA; Doherty JA; Goodman MT; Modugno F; Ness RB; Moysich KB; Kjær SK; Høgdall E; Jensen A; Schildkraut JM; Berchuck A; Cramer DW; Bandera EV; Wentzensen N; Kotsopoulos J; Narod SA; Phelan CM; McLaughlin JR; Anton-Culver H; Ziogas A; Pearce CL; Wu AH; Terry KL; ; Cancer Epidemiol Biomarkers Prev; 2018 Feb; 27(2):174-182. PubMed ID: 29141849 [No Abstract] [Full Text] [Related]
2. Long and irregular menstrual cycles, polycystic ovary syndrome, and ovarian cancer risk in a population-based case-control study. Harris HR; Titus LJ; Cramer DW; Terry KL Int J Cancer; 2017 Jan; 140(2):285-291. PubMed ID: 27667654 [TBL] [Abstract][Full Text] [Related]
3. Obesity, rather than menstrual cycle pattern or follicle cohort size, determines hyperinsulinaemia, dyslipidaemia and hypertension in ageing women with polycystic ovary syndrome. Elting MW; Korsen TJ; Schoemaker J Clin Endocrinol (Oxf); 2001 Dec; 55(6):767-76. PubMed ID: 11895219 [TBL] [Abstract][Full Text] [Related]
4. Association between genetically predicted polycystic ovary syndrome and ovarian cancer: a Mendelian randomization study. Harris HR; Cushing-Haugen KL; Webb PM; Nagle CM; Jordan SJ; ; Risch HA; Rossing MA; Doherty JA; Goodman MT; Modugno F; Ness RB; Moysich KB; Kjær SK; Høgdall E; Jensen A; Schildkraut JM; Berchuck A; Cramer DW; Bandera EV; Rodriguez L; Wentzensen N; Kotsopoulos J; Narod SA; McLaughlin JR; Anton-Culver H; Ziogas A; Pearce CL; Wu AH; Lindström S; Terry KL Int J Epidemiol; 2019 Jun; 48(3):822-830. PubMed ID: 31211375 [TBL] [Abstract][Full Text] [Related]
5. Appraising the role of previously reported risk factors in epithelial ovarian cancer risk: A Mendelian randomization analysis. Yarmolinsky J; Relton CL; Lophatananon A; Muir K; Menon U; Gentry-Maharaj A; Walther A; Zheng J; Fasching P; Zheng W; Yin Ling W; Park SK; Kim BG; Choi JY; Park B; Davey Smith G; Martin RM; Lewis SJ PLoS Med; 2019 Aug; 16(8):e1002893. PubMed ID: 31390370 [TBL] [Abstract][Full Text] [Related]
6. Women with polycystic ovary syndrome gain regular menstrual cycles when ageing. Elting MW; Korsen TJ; Rekers-Mombarg LT; Schoemaker J Hum Reprod; 2000 Jan; 15(1):24-8. PubMed ID: 10611183 [TBL] [Abstract][Full Text] [Related]
7. Clinical implications of menstrual cycle length in oligomenorrhoeic young women. Oh JY; Sung YA; Lee HJ Clin Endocrinol (Oxf); 2014 Jan; 80(1):115-21. PubMed ID: 23663009 [TBL] [Abstract][Full Text] [Related]
8. A genetic risk score is associated with polycystic ovary syndrome-related traits. Lee H; Oh JY; Sung YA; Chung HW Hum Reprod; 2016 Jan; 31(1):209-15. PubMed ID: 26573528 [TBL] [Abstract][Full Text] [Related]
9. Aging women with polycystic ovary syndrome who achieve regular menstrual cycles have a smaller follicle cohort than those who continue to have irregular cycles. Elting MW; Kwee J; Korsen TJ; Rekers-Mombarg LT; Schoemaker J Fertil Steril; 2003 May; 79(5):1154-60. PubMed ID: 12738511 [TBL] [Abstract][Full Text] [Related]
10. Offspring sex and risk of epithelial ovarian cancer: a multinational pooled analysis of 12 case-control studies. Modugno F; Fu Z; Jordan SJ; Group A; Chang-Claude J; Fortner RT; Goodman MT; Moysich KB; Schildkraut JM; Berchuck A; Bandera EV; Qin B; Sutphen R; McLaughlin JR; Menon U; Ramus SJ; Gayther SA; Gentry-Maharaj A; Karpinskyj C; Pearce CL; Wu AH; Risch HA; Webb PM Eur J Epidemiol; 2020 Nov; 35(11):1025-1042. PubMed ID: 32959149 [TBL] [Abstract][Full Text] [Related]
11. Ovarian surgery for symptom relief in women with polycystic ovary syndrome. Lepine S; Jo J; Metwally M; Cheong YC Cochrane Database Syst Rev; 2017 Nov; 11(11):CD009526. PubMed ID: 29125183 [TBL] [Abstract][Full Text] [Related]
12. Adolescent oligomenorrhea (age 14-19) tracks into the third decade of life (age 20-28) and predicts increased cardiovascular risk factors and metabolic syndrome. Glueck CJ; Woo JG; Khoury PR; Morrison JA; Daniels SR; Wang P Metabolism; 2015 Apr; 64(4):539-53. PubMed ID: 25633270 [TBL] [Abstract][Full Text] [Related]
13. Risk of epithelial ovarian tumors among women with polycystic ovary syndrome: A nationwide population-based cohort study. Frandsen CLB; Svendsen PF; Nøhr B; Viuff JH; Maltesen T; Kjaer SK; Jensen A Int J Cancer; 2023 Sep; 153(5):958-968. PubMed ID: 37357906 [TBL] [Abstract][Full Text] [Related]
14. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME--PART 1. Goodman NF; Cobin RH; Futterweit W; Glueck JS; Legro RS; Carmina E; ; ; Endocr Pract; 2015 Nov; 21(11):1291-300. PubMed ID: 26509855 [TBL] [Abstract][Full Text] [Related]
15. Irregular menstruation and hyperandrogenaemia in adolescence are associated with polycystic ovary syndrome and infertility in later life: Northern Finland Birth Cohort 1986 study. West S; Lashen H; Bloigu A; Franks S; Puukka K; Ruokonen A; Järvelin MR; Tapanainen JS; Morin-Papunen L Hum Reprod; 2014 Oct; 29(10):2339-51. PubMed ID: 25085801 [TBL] [Abstract][Full Text] [Related]
16. Oligo/Amenorrhea Is an Independent Risk Factor Associated With Low Ovarian Response. Hu KL; Gan K; Ying Y; Zheng J; Chen R; Xue J; Wu Y; Liu Y; Zhu Y; Xing L; Zhang D Front Endocrinol (Lausanne); 2021; 12():612042. PubMed ID: 34177795 [TBL] [Abstract][Full Text] [Related]
17. Increasing serum 25-hydroxyvitamin D is associated with reduced odds of long menstrual cycles in a cross-sectional study of African American women. Jukic AMZ; Upson K; Harmon QE; Baird DD Fertil Steril; 2016 Jul; 106(1):172-179.e2. PubMed ID: 26997249 [TBL] [Abstract][Full Text] [Related]
18. Risk of endometrial, ovarian and breast cancer in women with polycystic ovary syndrome: a systematic review and meta-analysis. Barry JA; Azizia MM; Hardiman PJ Hum Reprod Update; 2014; 20(5):748-58. PubMed ID: 24688118 [TBL] [Abstract][Full Text] [Related]
19. Anti-Müllerian Hormone Levels in Adolescence in Relation to Long-term Follow-up for Presence of Polycystic Ovary Syndrome. Caanen MR; Peters HE; van de Ven PM; Jüttner AMFM; Laven JSE; van Hooff MHA; Lambalk CB J Clin Endocrinol Metab; 2021 Mar; 106(3):e1084-e1095. PubMed ID: 33351079 [TBL] [Abstract][Full Text] [Related]
20. Association between menstrual cycle irregularities and endocrine and metabolic characteristics of the polycystic ovary syndrome. Panidis D; Tziomalos K; Chatzis P; Papadakis E; Delkos D; Tsourdi EA; Kandaraki EA; Katsikis I Eur J Endocrinol; 2013 Feb; 168(2):145-52. PubMed ID: 23109645 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]